Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9517 |
High Similarity |
NPD4584 |
Approved |
0.9103 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8841 |
High Similarity |
NPD8054 |
Approved |
0.8841 |
High Similarity |
NPD8053 |
Approved |
0.8645 |
High Similarity |
NPD4773 |
Phase 2 |
0.8645 |
High Similarity |
NPD4772 |
Phase 2 |
0.8625 |
High Similarity |
NPD4010 |
Discontinued |
0.859 |
High Similarity |
NPD7298 |
Approved |
0.8519 |
High Similarity |
NPD2898 |
Approved |
0.8497 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD2420 |
Approved |
0.8431 |
Intermediate Similarity |
NPD2421 |
Approved |
0.8415 |
Intermediate Similarity |
NPD8252 |
Approved |
0.8415 |
Intermediate Similarity |
NPD8251 |
Approved |
0.8415 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD4017 |
Approved |
0.8387 |
Intermediate Similarity |
NPD3641 |
Approved |
0.8387 |
Intermediate Similarity |
NPD3639 |
Approved |
0.8387 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.8385 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.8364 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8301 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.8293 |
Intermediate Similarity |
NPD27 |
Approved |
0.8293 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8267 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8153 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8153 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8148 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.8121 |
Intermediate Similarity |
NPD2969 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2970 |
Approved |
0.8086 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8061 |
Intermediate Similarity |
NPD3051 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7931 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7919 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7907 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7861 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7836 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7811 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7748 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7748 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7746 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7722 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7707 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7657 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD2488 |
Approved |
0.764 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7636 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7605 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7595 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7568 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7568 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7568 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7562 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7541 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7533 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3109 |
Approved |
0.75 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD824 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7366 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7366 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7366 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7366 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.736 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7321 |
Intermediate Similarity |
NPD5773 |
Approved |
0.732 |
Intermediate Similarity |
NPD3635 |
Approved |
0.732 |
Intermediate Similarity |
NPD3636 |
Approved |
0.732 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7314 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2606 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7253 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7249 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7249 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2156 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2155 |
Approved |
0.723 |
Intermediate Similarity |
NPD5303 |
Approved |
0.723 |
Intermediate Similarity |
NPD5304 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD823 |
Approved |
0.7215 |
Intermediate Similarity |
NPD817 |
Approved |
0.7209 |
Intermediate Similarity |
NPD2904 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7207 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7207 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7207 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7204 |
Intermediate Similarity |
NPD4420 |
Approved |
0.72 |
Intermediate Similarity |
NPD5938 |
Phase 3 |
0.7196 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7196 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD4104 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD4103 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1914 |
Approved |
0.716 |
Intermediate Similarity |
NPD5061 |
Approved |
0.716 |
Intermediate Similarity |
NPD5062 |
Approved |
0.7158 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7151 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7151 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7143
|
Intermediate Similarity |
NPD3296 |
Phase 1 |